SIM
Spark Investment Management’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,381
| Closed | -$8K | – | 188 |
|
|
2020
Q1 | $8K | Buy |
+11,381
| New | +$8K | ﹤0.01% | 361 |
|
|
2019
Q3 | – | Sell |
-37,500
| Closed | -$44K | – | 465 |
|
|
2019
Q2 | $44K | Sell |
37,500
-84,900
| -69% | -$99.6K | ﹤0.01% | 528 |
|
|
2019
Q1 | $335K | Buy |
122,400
+9,700
| +9% | +$26.5K | 0.02% | 441 |
|
|
2018
Q4 | $557K | Buy |
112,700
+18,100
| +19% | +$89.5K | 0.04% | 378 |
|
|
2018
Q3 | $1.11M | Sell |
94,600
-4,400
| -4% | -$51.4K | 0.06% | 366 |
|
|
2018
Q2 | $1.01M | Sell |
99,000
-6,600
| -6% | -$67.5K | 0.06% | 366 |
|
|
2018
Q1 | $786K | Sell |
105,600
-55,700
| -35% | -$415K | 0.05% | 356 |
|
|
2017
Q4 | $745K | Sell |
161,300
-120,900
| -43% | -$558K | 0.04% | 401 |
|
|
2017
Q3 | $993K | Hold |
282,200
| – | – | 0.05% | 391 |
|
|
2017
Q2 | $990K | Buy |
282,200
+93,500
| +50% | +$328K | 0.06% | 389 |
|
|
2017
Q1 | $879K | Sell |
188,700
-163,900
| -46% | -$763K | 0.06% | 436 |
|
|
2016
Q4 | $1.12M | Buy |
352,600
+5,100
| +1% | +$16.2K | 0.09% | 319 |
|
|
2016
Q3 | $1.15M | Buy |
347,500
+147,200
| +73% | +$487K | 0.09% | 310 |
|
|
2016
Q2 | $1.2M | Buy |
+200,300
| New | +$1.2M | 0.11% | 279 |
|
|
2016
Q1 | – | Sell |
-91,500
| Closed | -$575K | – | 805 |
|
|
2015
Q4 | $575K | Buy |
+91,500
| New | +$575K | 0.07% | 343 |
|
|
2015
Q3 | – | Sell |
-19,000
| Closed | -$657K | – | 718 |
|
|
2015
Q2 | $657K | Sell |
19,000
-82,636
| -81% | -$2.86M | 0.09% | 298 |
|
|
2015
Q1 | $4.02M | Buy |
+101,636
| New | +$4.02M | 0.56% | 28 |
|
|
2014
Q4 | – | Sell |
-17,200
| Closed | -$335K | – | 757 |
|
|
2014
Q3 | $335K | Buy |
+17,200
| New | +$335K | 0.05% | 423 |
|